AGREEMENT AND PLAN OF MERGER dated as of March 8, 2021 by and among ANI Pharmaceuticals, Inc., NILE MERGER SUB LLC, Novitium Pharma LLC, Esjay LLC, Chali Properties LLC, Chad Gassert, Muthusamy Shanmugam, Thorappadi Vijayaraj and SHAREHOLDER...Agreement and Plan of Merger • March 9th, 2021 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
EQUITY COMMITMENT AND INVESTMENT AGREEMENT dated as of March 8, 2021 by and among ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited PartnershipEquity Commitment and Investment Agreement • March 9th, 2021 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This EQUITY COMMITMENT AND INVESTMENT AGREEMENT, dated as of March 8, 2021 (this “Agreement”), is by and between ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Ampersand 2020 Limited Partnership, a Delaware limited partnership (the “Purchaser”).
SUPPORT AGREEMENTSupport Agreement • March 9th, 2021 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”) is dated as of March 8, 2021, by and among ANI Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Nile Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Parent (“Merger Sub”), Novitium Pharma LLC, a Delaware limited liability company (the “Company”), Esjay LLC, a Delaware limited liability company (“Esjay”), Chali Properties, LLC, a New Jersey limited liability company (“Chali”; Esjay, Chali, Muthusamy Shanmugam and Thorappadi Vijayaraj are sometimes individually referred to as a “Principal Member” and collectively as “Principal Members”), Chad Gassert, Muthusamy Shanmugam and Thorappadi Vijayaraj (sometimes referred to individually as a “Key Person” and collectively as “Key Persons”), the Company Members included on the signature pages hereto, Shareholder Representative Services LLC, a Colorado limited liability company solely in its capacity as representative of the Company Members (in such capacity,
